# Sanofi Ventures' Biotech Investments: 11 Startups in Its Portfolio (2026) > The 11 Biotech startups Sanofi Ventures has backed, by stage: $3.3B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/sanofi-ventures-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series B 4 - [*B* BioNTech](https://millionrounds.com/company/biontech) - [Fulcrum Therapeutics](https://millionrounds.com/company/fulcrum-therapeutics) - [T-Therapeutics](https://millionrounds.com/company/t-therapeutics) - [Matchpoint Therapeutics](https://millionrounds.com/company/matchpoint-therapeutics) ## Series C and later 3 - [Kymera Therapeutics](https://millionrounds.com/company/kymera-therapeutics) - [AdvanCell](https://millionrounds.com/company/advancell) - [Science 37](https://millionrounds.com/company/science-37) ## Series A 2 - [Icosavax](https://millionrounds.com/company/icosavax) - [*IP* Inozyme Pharma](https://millionrounds.com/company/inozyme-pharma) ## Stage not reported 2 - [Aetion](https://millionrounds.com/company/aetion) - [Veralox Therapeutics](https://millionrounds.com/company/veralox-therapeutics) ## Segment by segment ### Series B 4 startups · $1.5B raised - [*B* **BioNTech**](https://millionrounds.com/company/biontech) Germany $687M - [**Fulcrum Therapeutics**](https://millionrounds.com/company/fulcrum-therapeutics) Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause. United States $310M - [**T-Therapeutics**](https://millionrounds.com/company/t-therapeutics) T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge. United Kingdom $279M - [**Matchpoint Therapeutics**](https://millionrounds.com/company/matchpoint-therapeutics) Matchpoint Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021. United States $220M ### Series C and later 3 startups · $1.5B raised - [**Kymera Therapeutics**](https://millionrounds.com/company/kymera-therapeutics) Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation. United States $799M - [**AdvanCell**](https://millionrounds.com/company/advancell) AdvanCell is radiopharmaceutical firm that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment. Australia $438M - [**Science 37**](https://millionrounds.com/company/science-37) Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers. United States $236M ### Series A 2 startups · $235M raised - [**Icosavax**](https://millionrounds.com/company/icosavax) Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs. United States $119M - [*IP* **Inozyme Pharma**](https://millionrounds.com/company/inozyme-pharma) United States $116M ### Stage not reported 2 startups · $115M raised - [**Aetion**](https://millionrounds.com/company/aetion) Aetion provides real-world evidence (RWE) and outcomes-based analytics solutions to life science companies and payers. United States $74M - [**Veralox Therapeutics**](https://millionrounds.com/company/veralox-therapeutics) VERALOX Therapeutics is a clinical-stage biotechnology company based in Frederick, Maryland. United States $41M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Sanofi Ventures as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Co-investors **Who invests with Sanofi Ventures** 27 co-investors](https://millionrounds.com/portfolio-maps/sanofi-ventures-co-investors)[Sector portfolio **Coinbase Ventures' Web3 & Crypto portfolio** 168 startups · $5.7B](https://millionrounds.com/portfolio-maps/coinbase-web3-crypto-portfolio)[Sector portfolio **Salesforce Ventures' AI portfolio** 115 startups · $181B](https://millionrounds.com/portfolio-maps/salesforce-ventures-ai-portfolio)[Sector portfolio **Google Ventures' AI portfolio** 81 startups · $16B](https://millionrounds.com/portfolio-maps/gv-ai-portfolio)[Sector portfolio **Google Ventures' Biotech portfolio** 74 startups · $12B](https://millionrounds.com/portfolio-maps/gv-biotech-portfolio)[Sector portfolio **Samsung Next's AI portfolio** 72 startups · $9.8B](https://millionrounds.com/portfolio-maps/samsung-next-ai-portfolio) ## Raising from investors like Sanofi Ventures? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)